{!{types field=’prefix’ separator=’, ‘}!}{!{/types}!} {!{types field=’first-name’}!}{!{/types}!} {!{types field=’last-name’}!}{!{/types}!}

{!{types field=’degrees-or-credentials’ separator=’, ‘}!}{!{/types}!}

Women's College Hospital

{!{types field=’position’ separator=’, ‘}!}{!{/types}!}

Research Interests:

Brief Bio:

Mustafa is a skilled and dynamic physician who is passionate about clinical research and health system innovation including software solutions. He has over 10 years of experience in direct patient care and clinical trial management. He has also worked as CRA for GSK- clinical trial operations. He aspires to build a CRO in Pakistan and hopes to bridge the gap that exists on local gene pool in research and innovation. He was involved in developing and leading training material and courses to medical staff and has good presentation skills. In leisure time, he loves to act as a motivator for youth struggling with their career goals. He wishes to join toastmasters club for further skills.

Capstone Project:

In Canada, 10,000 hospitalizations and 3,000 deaths are attributed annually to influenza in older adults (ie. > 65 years old). They are a high-risk group which represents 14% of the Canadian population. The annual uptake of influenza vaccine among older adults remains approximately 70%, which is below the recommended 80% target set by the National Advisory Committee on Immunization (NACI). This sub- optimal vaccine coverage elevates the health risk in this population, with increased comorbidity complications, emergency hospitalization, secondary pneumonia, and flu-related deaths. The Influenza vaccine have been proven to be the most effective way of avoiding influenza-related health complications. The scope of this project is to assess and verify the factors that contribute to vaccination hesitancy (ie. refusal or reluctance for vaccination) in older adults, and subsequently to ideate and co- create a targeted strategy to increase vaccine uptake. This will be conducted in three phases; a quantitative phase, a qualitative phase, and a co-creation of a targeted strategy. The Toronto Translational Framework will be used to discover and define the needs to frame the problem space.

{!{types field=’prefix’ separator=’, ‘}!}{!{/types}!} {!{types field=’first-name’}!}{!{/types}!} {!{types field=’last-name’}!}{!{/types}!}

{!{types field=’degrees-or-credentials’ separator=’, ‘}!}{!{/types}!}

Women's College Hospital

{!{types field=’position’ separator=’, ‘}!}{!{/types}!}

Research Interests:

Brief Bio:

Mustafa is a skilled and dynamic physician who is passionate about clinical research and health system innovation including software solutions. He has over 10 years of experience in direct patient care and clinical trial management. He has also worked as CRA for GSK- clinical trial operations. He aspires to build a CRO in Pakistan and hopes to bridge the gap that exists on local gene pool in research and innovation. He was involved in developing and leading training material and courses to medical staff and has good presentation skills. In leisure time, he loves to act as a motivator for youth struggling with their career goals. He wishes to join toastmasters club for further skills.

Capstone Project:

In Canada, 10,000 hospitalizations and 3,000 deaths are attributed annually to influenza in older adults (ie. > 65 years old). They are a high-risk group which represents 14% of the Canadian population. The annual uptake of influenza vaccine among older adults remains approximately 70%, which is below the recommended 80% target set by the National Advisory Committee on Immunization (NACI). This sub- optimal vaccine coverage elevates the health risk in this population, with increased comorbidity complications, emergency hospitalization, secondary pneumonia, and flu-related deaths. The Influenza vaccine have been proven to be the most effective way of avoiding influenza-related health complications. The scope of this project is to assess and verify the factors that contribute to vaccination hesitancy (ie. refusal or reluctance for vaccination) in older adults, and subsequently to ideate and co- create a targeted strategy to increase vaccine uptake. This will be conducted in three phases; a quantitative phase, a qualitative phase, and a co-creation of a targeted strategy. The Toronto Translational Framework will be used to discover and define the needs to frame the problem space.